Clarus Therapeutics Holdings Inc. Made Headway
Wed, Apr 20, 2022 at 05:30 PM
Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ) rocketted at $2.08, representing a gain of 43.4%. On Tue, Apr 19, 2022, CRXT:NASDAQ hit a New 2-Week High of $1.45. The stock appeared on our News Catalysts scanner on Tue, Apr 19, 2022 at 10:21 AM in the 'MISCELLANEOUS' category. From Wed, Apr 06, 2022, the stock recorded 42.86% Up Days and 25.00% Green Days
The stock spiked on Thu, Apr 14, 2022 at $1.7 with a volume of 88M+.
About Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ)
Clarus Therapeutics Holdings Inc is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications.
Top 10 Gainers:
- ION Geophysical Corporation (IO:NYSE), 91.23%
- Winc Inc. (WBEV:NYSEMKT), 65.13%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 43.45%
- GWG Holdings, Inc. (GWGH:NASDAQ), 35.78%
- Borqs Technologies, Inc. (BRQS:NASDAQ), 31.11%
- Baosheng Media Group Holdings Limited (BAOS:NASDAQ), 25.24%
- Redbox Entertainment Inc. (RDBX:NASDAQ), 24.51%
- IT Tech Packaging, Inc. (ITP:NYSEMKT), 22.29%
- IDEX Biometrics ASA (IDBA:NASDAQ), 20.54%
- Target Hospitality Corp. (TH:NASDAQ), 20.4%